Accurate prostate tumour detection with multiparametric magnetic resonance imaging: Dependence on histological properties-Reference-Cited by-同舟云学术

Accurate prostate tumour detection with multiparametric magnetic resonance imaging: Dependence on histological properties

Published:2013-09-16 Issue:1 Volume:53 Page:88-95
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Borren Alie,Groenendaal Greetje,Moman Maaike R.,Boeken Kruger Arto E.,van Diest Paul J.,van Vulpen Marco,Philippens Marielle E. P.,van der Heide Uulke A.

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/0284186X.2013.837581

Reference25 articles.

1. Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: implications for conformal therapy planning

2. Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy

3. Simultaneous integrated boost of biopsy proven, MRI defined dominant intra-prostatic lesions to 95 Gray with IMRT: early results of a phase I NCI study

4. Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study

5. Prostate Cancer Localization with Dynamic Contrast-enhanced MR Imaging and Proton MR Spectroscopic Imaging

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical significance of prostate cancer identified by transperineal standard template biopsy in men with nonsuspicious multiparametric magnetic resonance imaging;Urologic Oncology: Seminars and Original Investigations;2024-02

2. Proton versus photon therapy for high-risk prostate cancer with dose escalation of dominant intraprostatic lesions: a preliminary planning study;Frontiers in Oncology;2023-11-08

3. Contrast agents for MRI and side effects;Nuclear Medicine and Molecular Imaging;2022

4. Robust dose‐painting‐by‐numbers vs. nonselective dose escalation for non‐small cell lung cancer patients;Medical Physics;2021-05-14

5. What to expect from a non-suspicious prostate MRI? A review;Progrès en Urologie;2020-12